* Medifast Inc MED.N MED is expected to show a fall in
quarterly revenue when it reports results on February 18 for
the period ending December 31 2024
* The Baltimore Maryland-based company is expected to
report a
40.2% decrease in revenue to $114.25 million from $191.02
million a year ago, according to the mean estimate from 2
analysts, based on LSEG data.The company's guidance on November
4 2024, for the period ended December 31, was for revenue
between $100.00 million and $120.00 million.
* LSEG's mean analyst estimate for Medifast Inc is for a
loss
of 16 cents per share. The company's EPS guidance on November 4
2024, for the period ended December 31, was between $-0.65 and
$-0.10
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Medifast
Inc is
$16.50, above its last closing price of $16.03.
This summary was machine generated February 14 at 21:16 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)